From the Literature

• Acalabrutinib Demonstrates Efficacy and Safety in Relapsed CLL
• Atezolizumab Shows Durable Response, Tolerability in Urothelial Carcinoma

• Anti-CD19 CAR T-Cells Show Promise in B-Cell Cancer
• Lenvatinib Prolongs Progression-Free Survival in Advanced Thyroid Cancer
• Ruxolitinib More Effective Than Standard Therapy in the Treatment of Polycythemia Vera

A Phase 3 Trial Comparing Axitinib and Sorafenib in Advanced Renal-Cell Cancer